Osteoporosis Risk Assessment | FRAX Model | Amgen

IDENTIFYING INDIVIDUALS AT INCREASED RISK OF FRACTURE CAN GUIDE TREATMENT STRATEGIES1

Whereas BMD provides the cornerstone for the diagnosis of osteoporosis, combining this with clinical risk factors can calculate a patient’s fracture risk and can guide specific treatment.1
Tools have been developed in order to assess fracture risk in postmenopausal women. These include individualized models which integrate known clinical risk factors and BMD assessments.
Additionally, the FRAX® model has been developed from studying population-based cohorts in Europe, North America, Asia and Australia to provide algorithms for the 10-year probability of both hip and major osteoporotic fractures.
Download the IOF One Minute Osteoporosis Risk Awareness Test here to assess your patient’s personal risk of fracture.
Download a localized FRAX® chart here.

References:
BMD: bone mineral density; FRAX: Fracture Risk Assessment Tool; IOF: International Osteoporosis Foundation.
  1. Kanis JA, et al. Osteoporos Int. 2013;24:23–57.

SMPC

The information contained in this site is for healthcare professionals only

I am a patient
I am a member of the public